Rheumatoid Arthritis Tied to Higher Risk for Lung Cancer
By Lori Solomon HealthDay Reporter
FRIDAY, Aug. 9, 2024 -- Rheumatoid arthritis (RA) is associated with a significantly increased risk for lung cancer, according to a study published online July 28 in Arthritis & Rheumatology.
Rebecca T. Brooks, M.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues evaluated lung cancer risk in people with RA and RA-interstitial lung disease (ILD). The analysis included 72,795 Veterans Health Administration patients with RA and 633,937 matched non-RA persons.
The researchers found that RA was independently associated with an increased lung cancer risk (adjusted hazard ratio [aHR], 1.58), which persisted in never-smokers (aHR, 1.65) and incident RA (aHR, 1.54). Prevalent RA-ILD (757 patients) was more strongly associated with lung cancer risk (aHR, 3.25) than RA without ILD (aHR, 1.57) compared with non-RA controls. Results were similar for both prevalent and incident RA-ILD (RA-ILD versus non-RA: aHR, 2.88).
"RA was associated with a >50 percent increased risk of lung cancer, and RA-ILD represented a particularly high-risk group with an approximate threefold increased risk," the authors write. "Increased lung cancer surveillance in RA, and especially RA-ILD, may be a useful strategy for reducing the burden posed by the leading cause of cancer death."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
WEDNESDAY, April 30, 2025 -- Patients with psoriatic arthritis (PsA) have delays in diagnosis compared with those with rheumatoid arthritis (RA), according to a study published...
Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC
TUESDAY, April 22, 2025 -- Prolonged disease control can be maintained for patients with advanced non-small cell lung cancer (NSCLC) who discontinue immune checkpoint inhibitors...
Breast, Colorectal Cancer Screening Higher Than Lung Cancer Screening
TUESDAY, April 15, 2025 -- Among individuals eligible for lung cancer screening (LCS), use of breast cancer screening (BCS) and colorectal cancer screening (CCS) is much higher...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.